Shigella lipopolysaccharide: structure, genetics, and vaccine development.
about
Development of Shigella sonnei live oral vaccines based on defined rfbInaba deletion mutants of Vibrio cholerae expressing the Shigella serotype D O polysaccharide.Mutagenesis of the Shigella flexneri autotransporter IcsA reveals novel functional regions involved in IcsA biogenesis and recruitment of host neural Wiscott-Aldrich syndrome proteinGenetics of lipopolysaccharide biosynthesis in enteric bacteria.The chemical composition of endotoxin isolated from intestinal strain of Desulfovibrio desulfuricans.
P2860
Shigella lipopolysaccharide: structure, genetics, and vaccine development.
description
1992 nî lūn-bûn
@nan
1992 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Shigella lipopolysaccharide: structure, genetics, and vaccine development.
@ast
Shigella lipopolysaccharide: structure, genetics, and vaccine development.
@en
type
label
Shigella lipopolysaccharide: structure, genetics, and vaccine development.
@ast
Shigella lipopolysaccharide: structure, genetics, and vaccine development.
@en
prefLabel
Shigella lipopolysaccharide: structure, genetics, and vaccine development.
@ast
Shigella lipopolysaccharide: structure, genetics, and vaccine development.
@en
P2093
P1476
Shigella lipopolysaccharide: structure, genetics, and vaccine development.
@en
P2093
A A Lindberg
H N Brahmbhatt
K N Timmis
P577
1992-01-01T00:00:00Z